Web19 jan. 2024 · Merus is also eligible to receive up to $540 million in potential development and commercialization milestones per product, for a total of up to approximately $1.6 … Web28 nov. 2024 · News Release Merus Announces Publication of an Abstract on Petosemtamab Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma for Plenary Session Oral Presentation at the AACR Annual Meeting 2024 and Provides a Program and Regulatory Update April 14, 2024 at 11:10 AM EDT View PDF …
Merus Announces Publication of an Abstract on Petosemtamab in …
WebNews Releases; Event Calendar; Analyst Coverage; Stock Information; FAQ’s; Email Alerts; Careers . Closing in on cancer. ... Merus N.V., Uppsalalaan 17, 3 rd & 4 th floor, 3584 … Web5 uur geleden · Merus met with the U.S. Food and Drug Administration ... This press release contains forward-looking statements within the meaning of the Private Securities … blackwake for console
Merus Presents Clinical Data on MCLA-145 at the ESMO
Web6 dec. 2024 · All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without … Web5 uur geleden · Investor and Media Inquiries: Sherri Spear Merus N.V. VP Investor Relations and Corporate Communications 617-821-3246 [email protected] Kathleen … Web5 jun. 2024 · Merus Presents Clinical Data on Zenocutuzumab (Zeno) in NRG1-fusion (NRG1+) Cancer at the 2024 American Society of Clinical Oncology (ASCO) Annual … blackwake free download pc 1.8.9